Table 2.   Clinical characteristics of treatment group.

	Combined treatment
At start of GnRHa
Age (yr)	12.3 ± 1.1
Height (cm)	140.4 ± 6.3
Bone age (yr)	12.6 ± 1.2
Dose of GnRHa (μg/kg)	62.6 ± 10.1
At start of AH
Age (yr)	13.3 ± 1.4
Height (cm)	145.5 ± 6.0
At cessation of GnRHa
Age (yr)	16.4 ± 1.2
Height (cm)	159.7 ± 2.9
Bone age (yr)	14.9 ± 0.5
Dose of GnRHa (μg/kg)	60.8 ± 32.9
GnRHa treatment years (yr)	4.1 ± 1.1
At cessation of AH
Age (yr)	16.7 ± 1.3
Height (cm)	161.1 ± 3.0
AH treatment years (yr)	3.4 ± 0.9
△BA/△CA during GnRHa	0.6 ± 0.2

GnRHa: GnRH analog. AH: anabolic steroid hormone. △BA/△CA: △bone age/△chronological age.